Management of acral myxoinflammatory fibroblastic sarcoma
Open Access
- 24 August 2010
- Vol. 116 (24), 5733-5739
- https://doi.org/10.1002/cncr.25567
Abstract
BACKGROUND: Acral myxoinflammatory fibroblastic sarcoma (AMFS) is a rare, low‐grade sarcoma that commonly affects the distal extremities. From the published cases, therapy for AMFS to date has been comprised of excision or amputation, with limited use of radiotherapy (RT) or chemotherapy. In this report, the outcome of 17 patients with AMFS treated at the study institution was reported. METHODS: A retrospective review of all cases of AMFS identified in the Sarcoma Database in the Department of Radiation Oncology at the study institution was conducted. Treatment records and data from follow‐up visits of patients were reviewed. RESULTS: Seventeen patients were identified. All the patients underwent surgical resection (15 excisions and 2 amputations). Positive surgical margins after excisions were noted in 5 patients and were widely positive in 1 patient. Of the 17 patients, 14 patients received some form of RT. The average total dose was 56.4 Gray (Gy). Eight patients received preoperative RT alone, 5 patients received preoperative RT and postoperative RT, and 1 patient received preoperative RT and intraoperative RT. Median follow‐up was 24.5 months. One patient presented with recurrent disease and was treated with resection, and both pre‐ and postoperative RT. He was free of disease 23 months after his last treatment. No local recurrence was noted in the remaining patients. Of the 14 patients undergoing preoperative RT, complete pathologic necrosis or no tumor was noted in 1 of the patients. No metastatic disease was observed in any of the patients. There was no significant radiation toxicity observed in any of the patients. CONCLUSIONS: Data were consistent with local control of distal extremity sarcomas with resection and RT, suggesting that limb‐sparing surgery with this treatment combination is an appropriate option in the limb‐sparing control of patients with AMFS, even those with positive surgical margins. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 19 references indexed in Scilit:
- Impact of Intensity-Modulated Radiation Therapy on Local Control in Primary Soft-Tissue Sarcoma of the ExtremityJournal of Clinical Oncology, 2008
- Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysisJournal of Cutaneous Pathology, 2007
- Acral myxoinflammatory fibroblastic sarcomas: are they all low‐grade neoplasms?Journal of Cutaneous Pathology, 2007
- Acral Myxoinflammatory Fibroblastic Sarcomas: MRI Findings in Four CasesAmerican Journal of Roentgenology, 2007
- Case Reports: Acral Myxoinflammatory Fibroblastic SarcomaClinical Orthopaedics and Related Research, 2006
- Low‐grade fibromyxoid sarcoma arising in the big toePathology International, 2005
- Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcomaRadiotherapy and Oncology, 2005
- Myxoinflammatory fibroblastic sarcoma: A tumor not restricted to acral sitesAnnals of Diagnostic Pathology, 2002
- Acral Myxoinflammatory Fibroblastic SarcomaThe American Journal of Surgical Pathology, 1998
- Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomaInternational Journal of Radiation Oncology*Biology*Physics, 1991